In response to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.

Hosseinpoor, Masoumeh; Kabiri, Mona; Bakhshaee, Mehdi

Hosseinpoor, Masoumeh; Kabiri, Mona; Bakhshaee, Mehdi.

Hosseinpoor M; Sinus and Surgical Endoscopic Research Center, Department of Otorhinolaryngology, Mashhad University of Medical Sciences, Mashhad, Iran.
Kabiri M; Pharmaceutical nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Bakhshaee M; Clinical Research Development Unit, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Laryngoscope ; 133(4): E31, 2023 04.

Article in English | MEDLINE | ID: covidwho-2263246

Subject(s)

COVID-19; Olfaction Disorders; Humans; COVID-19/complications; Smell; Administration, Intranasal; Olfaction Disorders/drug therapy; Olfaction Disorders/etiology; Adrenal Cortex Hormones/therapeutic use

Keywords

COVID-19; anosmia; corticosteroids; hyposmia; olfactory dysfunction

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Olfaction Disorders Topics: Long Covid Limits: Humans Language: English Journal: Laryngoscope Journal subject: Otolaryngology Year: 2023 Document Type: Article Affiliation country: Lary.30506

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google